Phase I/II trial of vandetanib in children and adolescents with hereditary medullary thyroid carcinoma

被引：0
|
作者：
Fox, E.
Widemann, B. C.
Whitcomb, P. O.
Aikin, A.
Dombi, E.
Lodish, M.
Stratakis, C. A.
Steinberg, S.
Wells, S. A., Jr.
Balis, F. M.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NICHD, Bethesda, MD USA
[3] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10014
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Medullary Thyroid Carcinoma in Children
    Graves, Claire E.
    Gosnell, Jessica E.
    SEMINARS IN PEDIATRIC SURGERY, 2020, 29 (03)
  • [42] Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
    Robinson, Bruce G.
    Paz-Ares, Luis
    Krebs, Annetta
    Vasselli, James
    Haddad, Robert
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06): : 2664 - 2671
  • [43] Medullary thyroid carcinoma in children
    Berdelou, Amandine
    Hartl, Dana
    Al Ghuzlan, Abir
    Mirghani, Haitham
    Chougnet, Cecile
    Baudin, Eric
    Schlumberger, Martin
    Leboulleux, Sophie
    BULLETIN DU CANCER, 2013, 100 (7-8) : 780 - 788
  • [44] Medullary thyroid carcinoma in children
    Niedziela, Marek
    Breborowicz, Danuta
    Kulinska-Niedziela, Izabela
    Breborowicz, Jan
    Maceluch, Jaroslaw
    Korman, Eugeniusz
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (04): : 161 - 165
  • [45] Phase II trial of sunitinib in medullary thyroid cancer (MTC)
    De Souza, J. A.
    Busaidy, N.
    Zimrin, A.
    Seiwert, T. Y.
    Villaflor, V. M.
    Poluru, K. B.
    Reddy, P. L.
    Nam, J.
    Vokes, E. E.
    Cohen, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study
    Phadnis, S.
    Wang, X.
    Daw, N. C.
    Subbiah, I. M.
    Zaky, W.
    Gouda, M. A.
    Morani, A. C.
    Amini, B.
    Harrison, D. J.
    Piha-Paul, S. A.
    Meric-Bernstam, F.
    Gorlick, R.
    Schwartz, C. L.
    Subbiah, V.
    ESMO OPEN, 2023, 8 (06)
  • [47] Phase II trial of regorafenib in metastatic medullary thyroid carcinoma (MTC) and radioactive iodine refractory differentiated thyroid carcinoma (RAIR DTC)
    Sehgal, Kartik
    Shi, Ruichao
    Pappa, Theodora
    Min, Judy K.
    Oakley, Liam B.
    ONeill, Anne
    Dennis, Michael J.
    Deshpande, Hari Anant
    Haddad, Robert I.
    Lorch, Jochen H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] TREATMENT WITH VANDETANIB IN A 11 YEARS OLD BOY WITH ADVANCED MEDULLARY THYROID CARCINOMA
    Papendieck, Patricia
    Vieites, Ana
    Elias, Eugenia
    Garcia Lombardi, Mercedes
    Chiesa, Ana
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 596 - 596
  • [49] Diagnostic and Surgical Dilemmas in Hereditary Medullary Thyroid Carcinoma
    Allen, Shawn M.
    Bodenner, Donald
    Suen, James Y.
    Richter, Gresham T.
    LARYNGOSCOPE, 2009, 119 (07): : 1303 - 1311
  • [50] Prophylactic thyroidectomy in cases with hereditary medullary thyroid carcinoma
    Gortz, G
    Kress, JH
    Schmid, KW
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1996, : 199 - 201
12345